| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.8 |